Analyst Consensus ?
ConsensusBuy52 ratings
Bullish4382.7%
Neutral713.5%
Bearish23.8%
FN2 Earnings Intelligence
UnitedHealth Group Incorporated (UNH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 11, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Mizuho | Outperform | Outperform | Maintain | Jul 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 20, 2026 |
| UBS | Buy | Buy | Maintain | Jul 17, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 17, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Baird | Neutral | Underperform | Upgrade | Jul 16, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 14, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 13, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 24, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | May 27, 2026 |
| Argus Research | Buy | Hold | Upgrade | Apr 22, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 20, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | Apr 1, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 29, 2025 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 26, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | May 20, 2025 |
| TD Securities | Hold | Buy | Downgrade | May 19, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | May 14, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Dec 5, 2024 |
| Erste Group | Hold | Buy | Downgrade | Mar 13, 2024 |
| SVB Securities | Outperform | Outperform | Maintain | Jun 14, 2023 |
| Loop Capital | Buy | Buy | Maintain | Apr 17, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Jan 17, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 7, 2022 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 20, 2022 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 14, 2021 |
| Citigroup | Buy | Buy | Maintain | Jul 16, 2021 |
| Seaport Global | Buy | Buy | Maintain | Jul 9, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 21, 2020 |
| Argus | Buy | Buy | Maintain | Dec 17, 2018 |
| Bank of America | Buy | Buy | Maintain | Oct 17, 2018 |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 17, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jan 4, 2017 |
| Evercore ISI Group | Buy | Buy | Maintain | Sep 23, 2016 |
| Cleveland Research | Buy | Buy | Maintain | Apr 8, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jun 26, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Jun 26, 2015 |
| Leerink Swann | Outperform | Outperform | Maintain | Mar 31, 2015 |
| Stifel Nicolaus | Buy | Buy | Maintain | Dec 3, 2014 |
| Stifel | Buy | Buy | Maintain | Dec 2, 2014 |
| FBR Capital | Outperform | Outperform | Maintain | Jul 18, 2014 |
| Monness, Crespi, Hardt | Sell | Neutral | Downgrade | Jan 21, 2014 |
| Monness Crespi Hardt | Sell | Neutral | Downgrade | Jan 21, 2014 |
| Standpoint Research | Hold | Buy | Downgrade | Jun 17, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 20, 2012 |
| Wedbush | Outperform | Outperform | Maintain | Apr 9, 2012 |
Upside is calculated against the persisted previous close $388.28. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $512 | $430.92 | +31.9% | Jul 21, 2026 |
| Mizuho Securities | Ann Hynes | $493 | $421.55 | +27.0% | Jul 20, 2026 |
| Wells Fargo | Stephen Baxter | $526 | $426.09 | +35.5% | Jul 20, 2026 |
| Barclays | Analyst unavailable | $441 | $426.09 | +13.6% | Jul 20, 2026 |
| Truist Financial | David MacDonald | $500 | $429.39 | +28.8% | Jul 17, 2026 |
| UBS | Analyst unavailable | $490 | $423.38 | +26.2% | Jul 17, 2026 |
| Morgan Stanley | Analyst unavailable | $529 | $423.38 | +36.2% | Jul 17, 2026 |
| KeyBanc | Matthew Gillmor | $500 | $423.38 | +28.8% | Jul 17, 2026 |
| Robert W. Baird | Michael Ha | $453 | $429.43 | +16.7% | Jul 16, 2026 |
| Piper Sandler | Jessica Tassan | $477 | $446.72 | +22.8% | Jul 16, 2026 |
| Piper Sandler | Analyst unavailable | $475 | $419.23 | +22.3% | Jul 15, 2026 |
| Truist Financial | Analyst unavailable | $480 | $429.09 | +23.6% | Jul 14, 2026 |
| KeyBanc | Matthew Gillmor | $475 | $429.09 | +22.3% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $485 | $424.62 | +24.9% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $463 | $433.88 | +19.2% | Jul 9, 2026 |
| HSBC | Sidharth Sahoo | $380 | $415.74 | -2.1% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $468 | $419.82 | +20.5% | Jun 30, 2026 |
| Leerink Partners | Whit Mayo | $462 | $407.65 | +19.0% | Jun 17, 2026 |
| Mizuho Securities | Analyst unavailable | $460 | $399.47 | +18.5% | Jun 8, 2026 |
| Morgan Stanley | Erin Wright | $453 | $377 | +16.7% | Jun 4, 2026 |
| Truist Financial | Analyst unavailable | $440 | $380.31 | +13.3% | Jun 1, 2026 |
| H.C. Wainwright | Analyst unavailable | $492 | $376.86 | +26.7% | May 27, 2026 |
| Bernstein | Analyst unavailable | $492 | $376.86 | +26.7% | May 27, 2026 |
| Barclays | Analyst unavailable | $429 | $378.99 | +10.5% | May 26, 2026 |
| UBS | Analyst unavailable | $460 | $382.48 | +18.5% | May 22, 2026 |
| Mizuho Securities | Analyst unavailable | $440 | $389.24 | +13.3% | May 20, 2026 |
| Goldman Sachs | Analyst unavailable | $435 | $370.48 | +12.0% | May 1, 2026 |
| Jefferies | Analyst unavailable | $373 | $324.63 | -3.9% | Apr 20, 2026 |
| Truist Financial | David MacDonald | $370 | $287.2 | -4.7% | Feb 2, 2026 |
| Wells Fargo | Stephen Baxter | $370 | $292.29 | -4.7% | Jan 30, 2026 |
| Barclays | Andrew Mok | $327 | $292.29 | -15.8% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $361 | $291.25 | -7.0% | Jan 28, 2026 |
| KeyBanc | Analyst unavailable | $405 | $288.01 | +4.3% | Jan 28, 2026 |
| UBS | Analyst unavailable | $410 | $291 | +5.6% | Jan 28, 2026 |
| Oppenheimer | Michael Wiederhorn | $385 | $282.7 | -0.8% | Jan 28, 2026 |
| Morgan Stanley | Erin Wright | $375 | $282.7 | -3.4% | Jan 28, 2026 |
| Leerink Partners | Analyst unavailable | $345 | $282.7 | -11.1% | Jan 28, 2026 |
| Piper Sandler | Analyst unavailable | $396 | $281.73 | +2.0% | Jan 27, 2026 |
| Morgan Stanley | Erin Wright | $409 | $356.26 | +5.3% | Jan 25, 2026 |
| Bernstein | Analyst unavailable | $444 | $348.55 | +14.4% | Jan 6, 2026 |
| Evercore ISI | Elizabeth Anderson | $400 | $342.02 | +3.0% | Jan 6, 2026 |
| Barclays | Andrew Mok | $391 | $336.4 | +0.7% | Jan 5, 2026 |
| Bernstein | Analyst unavailable | $440 | $355.26 | +13.3% | Oct 30, 2025 |
| UBS | Analyst unavailable | $430 | $361.96 | +10.7% | Oct 29, 2025 |
| RBC Capital | Ben Hendrix | $408 | $361.96 | +5.1% | Oct 29, 2025 |
| Oppenheimer | Analyst unavailable | $415 | $367.84 | +6.9% | Oct 29, 2025 |
| Leerink Partners | Whit Mayo | $410 | $367.84 | +5.6% | Oct 29, 2025 |
| Deutsche Bank | Analyst unavailable | $333 | $367.84 | -14.2% | Oct 29, 2025 |
| Piper Sandler | Jessica Tassan | $417 | $367.81 | +7.4% | Oct 28, 2025 |
| Jefferies | David Windley | $409 | $356.67 | +5.3% | Oct 17, 2025 |
| Truist Financial | Analyst unavailable | $410 | $357.55 | +5.6% | Oct 14, 2025 |
| Goldman Sachs | Analyst unavailable | $406 | $358.66 | +4.6% | Oct 14, 2025 |
| Mizuho Securities | Analyst unavailable | $430 | $369.92 | +10.7% | Oct 9, 2025 |
| Barclays | Andrew Mok | $386 | $369.92 | -0.6% | Oct 9, 2025 |
| Bernstein | Analyst unavailable | $433 | $363.66 | +11.5% | Oct 8, 2025 |
| UBS | Analyst unavailable | $400 | $363.66 | +3.0% | Oct 8, 2025 |
| Wells Fargo | Analyst unavailable | $400 | $358.77 | +3.0% | Oct 7, 2025 |
| Morgan Stanley | Analyst unavailable | $325 | $346.78 | -16.3% | Sep 10, 2025 |
| Truist Financial | Analyst unavailable | $365 | $347.92 | -6.0% | Sep 9, 2025 |
| Bernstein | Analyst unavailable | $379 | $315.39 | -2.4% | Sep 5, 2025 |
| Barclays | Andrew Mok | $352 | $310.38 | -9.3% | Sep 4, 2025 |
| Barclays | Andrew Mok | $362 | $307.88 | -6.8% | Sep 4, 2025 |
| Robert W. Baird | Analyst unavailable | $198 | $266.04 | -49.0% | Jul 31, 2025 |
| Piper Sandler | Analyst unavailable | $317 | $266.04 | -18.4% | Jul 30, 2025 |
| UBS | Analyst unavailable | $385 | $302.02 | -0.8% | Jun 25, 2025 |
| HSBC | Sidharth Sahoo | $270 | $302.98 | -30.5% | May 21, 2025 |
| Wolfe Research | Justin Lake | $390 | $321.58 | +0.4% | May 20, 2025 |
| Truist Financial | David MacDonald | $360 | $315.89 | -7.3% | May 19, 2025 |
| Mizuho Securities | Ann Hynes | $350 | $291.91 | -9.9% | May 16, 2025 |
| RBC Capital | Ben Hendrix | $355 | $291.91 | -8.6% | May 16, 2025 |
| Morgan Stanley | Erin Wright | $374 | $378.75 | -3.7% | May 14, 2025 |
| RBC Capital | Ben Hendrix | $525 | $311.38 | +35.2% | May 13, 2025 |
| KeyBanc | Analyst unavailable | $575 | $425.33 | +48.1% | Apr 21, 2025 |
| Jefferies | David Windley | $635 | $549.53 | +63.5% | Dec 9, 2024 |
| RBC Capital | Ben Hendrix | $595 | $556.29 | +53.2% | Oct 16, 2024 |
| Truist Financial | David MacDonald | $625 | $556.29 | +61.0% | Oct 16, 2024 |
| Bank of America Securities | Joanna Gajuk | $650 | $556.29 | +67.4% | Oct 16, 2024 |
| Jefferies | David Windley | $643 | $556.29 | +65.6% | Oct 16, 2024 |
| Deutsche Bank | George Hill | $595 | $556.29 | +53.2% | Oct 16, 2024 |
| KeyBanc | Matthew Gillmor | $650 | $569.66 | +67.4% | Oct 16, 2024 |
| KeyBanc | Matthew Gillmor | $675 | $597.7 | +73.8% | Oct 10, 2024 |
| Argus Research | David Toung | $600 | $565.78 | +54.5% | Jul 17, 2024 |
| Truist Financial | David MacDonald | $640 | $548.87 | +64.8% | Jul 17, 2024 |
| Stephens | Scott Fidel | $600 | $548.87 | +54.5% | Jul 17, 2024 |
| Jefferies | David Windley | $647 | $573.28 | +66.6% | Jul 17, 2024 |
| HSBC | Sidharth Sahoo | $580 | $503.12 | +49.4% | Jun 5, 2024 |
| Deutsche Bank | George Hill | $562 | $493.18 | +44.7% | Apr 19, 2024 |
| Wells Fargo | Stephen Baxter | $525 | $483.16 | +35.2% | Apr 17, 2024 |
| RBC Capital | Ben Hendrix | $555 | $468.89 | +42.9% | Apr 17, 2024 |
| Piper Sandler | Jessica Tassan | $571 | $468.89 | +47.1% | Apr 17, 2024 |
| Piper Sandler | Jessica Tassan | $566 | $450.05 | +45.8% | Apr 11, 2024 |
| Morgan Stanley | Erin Wright | $584 | $455.38 | +50.4% | Apr 5, 2024 |
| HSBC | Rajesh Kumar | $460 | $454.65 | +18.5% | Apr 4, 2024 |
| Oppenheimer | Michael Wiederhorn | $610 | $483.46 | +57.1% | Jul 17, 2023 |
| Raymond James | Strong Buy | $630 | $510.86 | +62.3% | Apr 5, 2023 |
| Credit Suisse | Analyst unavailable | $610 | $542.48 | +57.1% | Dec 7, 2022 |
| Morgan Stanley | Analyst unavailable | $587 | $525.18 | +51.2% | Nov 23, 2022 |
| Raymond James | Analyst unavailable | $635 | $512.08 | +63.5% | Sep 22, 2022 |
| Deutsche Bank | Analyst unavailable | $569 | $525.08 | +46.5% | Sep 8, 2022 |
| Mizuho Securities | Analyst unavailable | $600 | $537.43 | +54.5% | Aug 10, 2022 |
| UBS | Kavin Caliendo | $570 | $542.52 | +46.8% | Aug 3, 2022 |
| Argus Research | Analyst unavailable | $650 | $528.49 | +67.4% | Jul 25, 2022 |
| Deutsche Bank | Analyst unavailable | $556 | $528.98 | +43.2% | Jul 19, 2022 |
| Leerink Partners | Analyst unavailable | $625 | $525.3 | +61.0% | Jul 18, 2022 |
| Credit Suisse | Analyst unavailable | $579 | $525.87 | +49.1% | Jul 18, 2022 |
| Wells Fargo | Stephen Baxter | $612 | $507.11 | +57.6% | May 31, 2022 |
| BMO Capital | Matt Borsch | $600 | $517.57 | +54.5% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $613 | $537.44 | +57.9% | Apr 22, 2022 |
| RBC Capital | Ben Hendrix | $588 | $537.7 | +51.4% | Apr 20, 2022 |
| Mizuho Securities | Ann Hynes | $550 | $534.82 | +41.7% | Apr 14, 2022 |
| UBS | Kevin Caliendo | $545 | $537 | +40.4% | Apr 13, 2022 |
| Truist Financial | David S Macdonald | $610 | $536.95 | +57.1% | Apr 7, 2022 |
| Jefferies | David Windley | $485 | $531.75 | +24.9% | Apr 6, 2022 |
| Barclays | Steve Valiquette | $565 | $512.59 | +45.5% | Apr 3, 2022 |
| Leerink Partners | Whit Mayo | $550 | $466.06 | +41.7% | Jan 30, 2022 |
| UBS | Kevin Caliendo | $468 | $461.63 | +20.5% | Jan 20, 2022 |
| Evercore ISI | Michael Newshel | $480 | $461.16 | +23.6% | Jan 19, 2022 |
| RBC Capital | Ben Hendrix | $563 | $461.16 | +45.0% | Jan 19, 2022 |
| Bank of America Securities | Kevin Fischbeck | $574.2 | $461.16 | +47.9% | Jan 19, 2022 |
| Seaport Global | Joseph France | $525 | $467.31 | +35.2% | Jan 14, 2022 |
| Bernstein | Lance Wilkes | $564 | $467.62 | +45.3% | Jan 11, 2022 |
| J.P. Morgan | Lisa Gill | $540 | $485.68 | +39.1% | Dec 17, 2021 |
| Goldman Sachs | Nathan Rich | $535 | $478.04 | +37.8% | Dec 14, 2021 |
| Stephens | Scott Fidel | $475 | $441.59 | +22.3% | Dec 1, 2021 |
| Morgan Stanley | Ricky Goldwasser | $526 | $441.59 | +35.5% | Dec 1, 2021 |
| Credit Suisse | A.J. Rice | $495 | $425.42 | +27.5% | Oct 15, 2021 |
| Oppenheimer | Michael Wiederhorn | $475 | $425.42 | +22.3% | Oct 15, 2021 |
| Cantor Fitzgerald | Steven Halper | $465 | $417.76 | +19.8% | Oct 14, 2021 |
| Wolfe Research | Justin Lake | $442 | $390.6 | +13.8% | Apr 26, 2021 |
| Argus Research | David Toung | $450 | $393.51 | +15.9% | Apr 21, 2021 |
Track every rating change on UNH the moment it posts. Free to start.
Start free